Lo Monaco, Maria Rita
 Distribuzione geografica
Continente #
NA - Nord America 1.942
EU - Europa 1.590
AS - Asia 498
AF - Africa 55
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 4.100
Nazione #
US - Stati Uniti d'America 1.916
IT - Italia 436
SE - Svezia 353
DE - Germania 230
IE - Irlanda 153
CN - Cina 142
HK - Hong Kong 125
SG - Singapore 107
FR - Francia 83
GB - Regno Unito 66
RU - Federazione Russa 56
CI - Costa d'Avorio 50
BE - Belgio 46
UA - Ucraina 45
IN - India 43
PL - Polonia 33
TR - Turchia 24
CA - Canada 23
FI - Finlandia 22
NL - Olanda 21
IR - Iran 20
AT - Austria 11
CZ - Repubblica Ceca 11
JP - Giappone 11
KR - Corea 9
CH - Svizzera 7
IL - Israele 7
BR - Brasile 6
ES - Italia 6
RO - Romania 5
EU - Europa 4
AU - Australia 3
EG - Egitto 3
VN - Vietnam 3
DK - Danimarca 2
LU - Lussemburgo 2
MX - Messico 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CL - Cile 1
DZ - Algeria 1
GR - Grecia 1
KE - Kenya 1
KZ - Kazakistan 1
MN - Mongolia 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
Totale 4.100
Città #
Chandler 426
Ashburn 268
Dublin 153
Ann Arbor 117
Rome 108
New York 96
Milan 93
Singapore 61
Chicago 51
Abidjan 50
Boardman 46
Cattolica 43
Moscow 43
Princeton 42
San Mateo 42
Wilmington 40
Brussels 36
Boston 35
Marseille 35
Warsaw 31
Nanjing 27
Jacksonville 24
Dearborn 23
Houston 21
Izmir 21
Los Angeles 21
Redwood City 21
Woodbridge 21
Fairfield 20
Washington 20
Bremen 18
Ottawa 17
Trieste 16
Pune 14
Beijing 13
Cambridge 13
Lancaster 12
Leawood 12
Nürnberg 12
Amsterdam 11
Brno 11
Helsinki 11
Kish 11
Redmond 11
Seattle 11
Norwalk 10
Augusta 9
Andover 8
Hong Kong 8
Tokyo 8
Vienna 8
Busto Arsizio 7
Jiaxing 7
Berlin 6
Guangzhou 6
Mountain View 6
Munich 6
Naples 6
Changsha 5
Edinburgh 5
Falls Church 5
Fremont 5
Hangzhou 5
Hebei 5
Lappeenranta 5
Shenyang 5
Zurich 5
Bari 4
Council Bluffs 4
Lawrence 4
Marino 4
Nanchang 4
Parma 4
Sant'Agostino 4
Ahvaz 3
Boydton 3
Cairo 3
Caldogno 3
Duisburg 3
Esslingen am Neckar 3
Getafe 3
Hefei 3
Kassel 3
Kunming 3
London 3
Londrina 3
Newark 3
Perugia 3
Saint Petersburg 3
Springfield 3
Tappahannock 3
Toronto 3
Atlanta 2
Bologna 2
Caserta 2
Central District 2
Chiswick 2
Cologne 2
Dong Ket 2
Fuzhou 2
Totale 2.466
Nome #
Teaching neuroimages: Peroneal intraneural ganglion cyst: a rare cause of drop foot in a child. 201
The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease Select item 29019160 1. The role of cognitive reserve in cognitive aging: what we can learn from Parkinson's disease. 160
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 153
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 138
Assessment of neurological manifestations in hospitalized patients with COVID-19 112
Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study 106
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 98
Laterality in Parkinson's disease may predict motor and visual imagery abilities 95
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 94
Use of ACE-inhibitors and falls in patients with Parkinson's disease 92
The impact of cognitive reserve on the effectiveness of balance rehabilitation in Parkinson's disease 90
The “development of metabolic and functional markers of dementia in older people” (ODINO) study: Rationale, design and methods 89
Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease 85
Use of proton-pump inhibitors is associated with depression: a population-based study 80
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 77
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 76
Word selection processing in Parkinson's disease: When nouns are more difficult than verbs 74
Association of metabolic syndrome with falls in patients with Parkinson's disease 73
Comparison of virtual reality rehabilitation and conventionalrehabilitation in Parkinson’s disease: a randomised controlledtrial 73
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 73
Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study 66
Safinamide as an adjunct therapy in older patients with Parkinson’s disease: a retrospective study 65
Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors 64
What about the caregiver? A journey into Parkinson’s disease following the burden tracks 64
The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection 64
Residual respiratory impairment after COVID-19 pneumonia 64
Writing errors in primary progressive aphasia 62
Circulating amino acid signature in older people with Parkinson's disease: A metabolic complement to the EXosomes in PArkiNson Disease (EXPAND) study 60
Sarcopenia in Parkinson Disease: Comparison of Different Criteria and Association With Disease Severity 59
Gender may be related to the side of the motorsyndrome and cognition in idiopathic Parkinson’sdisease 59
The Geriatrician: The Frontline Specialist in the Treatment of COVID-19 Patients 57
Balancing the risks and benefits of antipsychotic medications for symptom management in older patients with cancer 56
Untangling the relationship between fat distribution, nutritional status and Parkinson's disease severity 54
Association of Pisa Syndrome With Mortality in Patients With Parkinson's Disease 47
Association between frailty and ischemic heart disease: a systematic review and meta-analysis 47
Theory of mind: A clue for the interpretation of functional movement disorders 46
Polypharmacy is a determinant of hospitalization in Parkinson's disease 46
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 46
Residual respiratory impairment after COVID-19 pneumonia 44
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 44
Emotional valence may influence memory performance for visual artworks in Parkinson’s disease 42
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 41
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end? 40
Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19 39
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 38
Encephalopathy as neurological involvement of SARS-COV-2 infection 38
Mitochondrial dysfunction and aging: Insights from the analysis of extracellular vesicles 37
Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease 36
Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease 36
What about the caregiver? A journey into Parkinson's disease following the burden tracks 34
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 32
An educational case series of Parkinson's disease during the COVID-19 pandemic 32
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up 27
Impaired processing of conspecifics in Parkinson's disease 26
The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection 25
Correction to: Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 24
The Geriatrician: The Frontline Specialist in the Treatment of COVID-19 Patients 24
Fucntional and clinical correlates of carotid intimal thickness in obstructive sleep apnea syndrome 24
Safinamide as an adjunct therapy in older patients with Parkinson's disease: a retrospective study 22
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation 22
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 22
Should face masks be worn to contain the spread of COVID-19 in the postlockdown phase? 21
Association between frailty and ischemic heart disease: a systematic review and meta-analysis 21
Should face masks be worn to contain the spread of COVID-19 in the postlockdown phase? 21
Comparison of virtual reality rehabilitation and conventional rehabilitation in Parkinson's disease: a randomised controlled trial 21
An educational case series of Parkinson's disease during the COVID-19 pandemic 19
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation 19
Theory of mind: A clue for the interpretation of functional movement disorders 19
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end? 18
STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson's disease 18
Correction to: Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington’s disease (Journal of Neurology, (2022), 269, 12, (6634-6640), 10.1007/s00415-022-11297-3) 18
COVID-19 atypical Parsonage-Turner syndrome: a case report 17
Malnutrition in COVID-19 survivors: prevalence and risk factors 17
Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey 17
Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study 15
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up 14
Subacute onset dystonia in a woman affected by Parkinson's disease following SARS-COV-2 infection 13
Writing errors in primary progressive aphasia 13
Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure 12
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 11
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 11
Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19 11
Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson's Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study 11
Coronary risk factors in the elderly: Their interactions and treatment 10
The effects of cognitive impairment on mortality among hospitalized patients with heart failure 10
Of microbes and minds: A narrative review on the second brain aging 9
Subacute onset dystonia in a woman affected by Parkinson's disease following SARS-COV-2 infection 9
Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson's Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study 8
The “development of metabolic and functional markers of dementia in older people” (ODINO) study: Rationale, design and methods 7
Clinical and MRI characterization of apraxic syndrome in corticobasal degeneration: A single-case study 6
Social cognition in Parkinson's disease and functional movement disorders 5
Totale 4.235
Categoria #
all - tutte 23.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020236 0 7 8 10 30 20 36 13 16 24 58 14
2020/2021353 27 19 10 26 40 25 58 14 29 46 42 17
2021/2022517 35 20 13 43 30 17 15 81 14 38 103 108
2022/20231.533 153 157 80 207 73 160 105 101 326 87 69 15
2023/20241.157 36 237 74 80 72 194 75 63 16 70 100 140
2024/202579 47 32 0 0 0 0 0 0 0 0 0 0
Totale 4.235